Given that metabolic syndrome, including insulin resistance and glucose intolerance, is highly associated with AD (Vanhanen et al., 2006; Razay et al., 2007), we speculate that SHIP2 may play a dual role in AD and diabetes. This evidence concerns the gene INPPL1 and diabetes mellitus.